Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN113735867B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel chiral synthesis method offers high yield and enantioselectivity for antitumor drug intermediates, ensuring supply chain stability.
Patent CN113735867B reveals high-yield chiral synthesis. Enables cost reduction and supply reliability for pharmaceutical intermediate manufacturing globally.
Novel synthesis method using chiral phosphoric acid. High yield, mild conditions. Reliable supply for pharma intermediates. Cost effective manufacturing solution.
Patent CN113735867B reveals mild chiral phosphoric acid catalysis for high-purity pharmaceutical intermediates with significant cost and supply chain advantages.
Patent CN113735867B reveals high-yield chiral synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Patent CN113735867B reveals high-yield chiral synthesis for anticancer leads. Offers cost reduction in API intermediate manufacturing and supply chain reliability.